Timothy A. Gillespy;Laurence Ga;Stephanie D. Deprets;Brian Pedgrift;Christopher D. Edlin;Didier Babin;Shelley Amendola;Michael L. Edwards;Paul J. Cox;Charles J. Gardner;Andrew D. Morley;Herve Bouchard
发明人:
Michael L. Edwards,Paul J. Cox,Shelley Amendola,Stephanie D. Deprets,Timothy A. Gillespy,Christopher D. Edlin,Andrew D. Morley,Charles J. Gardner,Brian Pedgrift,Herve Bouchard,Didier Babin,Laurence Ga
申请号：
US11029064
公开号：
US08288425B2
申请日:
2005.01.04
申请国别(地区):
US
年份:
2012
代理人:
摘要：
The invention is directed to physiologically active compounds of the general formula (Ix)and compositions containing such compounds, and their prodrugs, and pharmaceutically acceptable salts and solvates of such compounds and their prodrugs, as well as to novel compounds within the scope of formula (Ix), and to processes for their preparation. Such compounds and compositions have valuable pharmaceutical properties, in particular the ability to inhibit kinases.
